Erythrocyte zinc, copper, and copper/zinc superoxide dismutase and risk of sporadic amyotrophic lateral sclerosis: A population-based case-control study

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 3, Issue 4, 2002, Pages 208-214

  Vinceti, Marco ^a   Bergomi, Margherita ^a   Nacci, Grazia ^a   Pietrini, Vladimiro ^b   Ferrari, Angela ^a   Fortini, Katia ^a   Guidetti, Donata ^c   Sola, Patrizia ^a   Rocchi, Enrico ^d   Mancia, Domenico ^b   Vivoli, Gianfranco ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d Emilia Romagna Region ^*  (Italy)

Author keywords

Amyotrophic lateral sclerosis; Case control study; Copper; Superoxide dismutase; Zinc

Indexed keywords

ALUMINUM; CADMIUM; CHROMIUM; COBALT; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; IRON; LEAD; MANGANESE; SELENIUM; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; BIOCHEMISTRY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE; HUMAN; HUMAN CELL; HYPOTHESIS; ITALY; PATHOGENESIS; PHYSICAL DISABILITY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCORING SYSTEM;

EID: 12244249838     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/146608202760839006     Document Type: Review

References (55)

1. Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:235-50.
2. Julien JP. Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell 2001; 104: 581-591.
3. Rotilio G, Carri MT, Ferri A, Gabbianelli R. Superoxide dismutase and amyotrophic lateral sclerosis. Free Radicals in Brain Pathophysiology. New York: Marcel Dekker, 2000: 393-409.
4. Maier CM, Chan PH. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002; 8: 323-334.
5. Elliott JL. Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 1169-1185.
6. Perry G, Sayre LM, Atwood CS, et al. The role of iron and copper in the etiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 2002; 16: 339-352.
7. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124 Suppl: 96-107.
8. Vinceti M, Guidetti D, Pinotti M, et al. Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content. Epidemiology 1996; 7: 529-532.
9. Guidetti D, Bondavalli M, Sabadini R, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996; 15: 301-312.
10. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 1996; 53: 141-147.
11. Bergomi M, Vinceti M, Nacci G, et al. Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: a population-based case-control study. Environ Res 2002;89:116-123.
12. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
13. Bergomi M, Rovesti S, Vinceti M, Vivoli R, Caselgrandi E, Vivoli G. Zinc and copper status and blood pressure. J Trace Elem Med Biol 1997; 11: 166-169.
14. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
15. Andersen PM, Nilsson P, Forsgren L, Marklund SL. CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutation. J Neurochem 1998; 70: 715-720.
16. Mase G, Ros S, Gemma A, et al. ALS with variable phenotypes in a six-generation family caused by leu144phe mutation in the SOD1 gene. J Neurol Sci 2001; 191: 11-18.
17. Kato M, Aoki M, Ohta M, et al. Marked reduction of the Cu/Zn superoxide dismutase polypeptide in a case of familial amyotrophic lateral sclerosis with the homozygous mutation. Neurosci Lett 2001; 312: 165-168.
18. Sugawara T, Lewen A, Gasche Y, Yu F, Chan PH. Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J (in press).
19. Borg J, London J. Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J Neurosci Res 2002; 70: 180-189.
20. Cleveland DW, Liu J. Oxidation versus aggregation - how do SOD1 mutants cause ALS? Nat Med 2000; 6: 1320-1321.
21. Cookson MR, Menzies FM, Manning P, et al. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3: 75-85.
22. Lino MM, Schneider C, Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 2002; 22: 4825-4832.
23. Lee JP, Gerin C, Bindokas VP, Miller R, Ghadge G, Roos RP. No correlation between aggregates of Cu/Zn superoxide dismutase and cell death in familial amyotrophic lateral sclerosis. J Neurochem 2002; 82: 1229-1238.
24. Rakhit R, Cunningham P, Furtos-Matei A, et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem (in press).
25. Subramaniam JR, Lyons WE, Liu J, et al. Mutant SOD1 causes motor neuron disease independent of copper chaperone- mediated copper loading. Nat Neurosci 2002; 5: 301-307.
26. Orr HT. A proposed mechanism of ALS fails the test in vivo. Nat Neurosci 2002; 5: 287-288.
27. Iwasaki Y, Ikeda K, Kinoshita M. Decreased cerebrospinal fluid superoxide dismutase in amyotrophic lateral sclerosis. Lancet 1993; 342: 1118.
28. Uchino M, Ando Y, Tanaka Y, et al. Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis. J Neurol Sci 1994;127:61-67.
29. Bergeron C, Muntasser S, Somerville MJ, Weyer L, Percy ME. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons. Brain Res 1994; 659: 272-276.
30. Shaw IC, Fitzmaurice PS, Mitchell JD, Lynch PG. Studies on cellular free radical protection mechanisms in the anterior horn from patients with amyotrophic lateral sclerosis. Neurodegeneration 1995; 4: 391-396.
31. Blaauwgeers HG, Vianney de Jong JM, Verspaget HW, van den Berg FM, Troost D. Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis. J Neurol Sci 1996; 140: 21-29.
32. Shibata N, Asayama K, Hirano A, Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 1996; 18: 492-498.
33. Przedborski S, Donaldson DM, Murphy PL, et al. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration 1996; 5: 57-64.
34. Oteiza PI, Uchitel OD, Carrasquedo F, Dubrovski AL, Roma JC, Fraga CG. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 1997; 22: 535-539.
35. Mitchell JD, Gatt JA, Phillips TM, et al. Cu/Zn superoxide dismutase free radicals, and motoneuron disease. Lancet 1993;342:1051-1052.
36. Puymirat J, Cossette L, Gosselin F, Bouchard JP. Red blood cell Cu/Zn superoxide dismutase activity in sporadic amyotrophic lateral sclerosis. J Neurol Sci 1994; 127: 121-123.
37. Robberecht W, Sapp P, Viaene MK, et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1994; 62: 384-387.
38. Fiszman ML, Borodinsky LN, Ricart KC, Sanz OP, Sica RE. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis. J Neurol Sci 1999; 162:34-37.
39. Torsdottir G, Kristinsson J, Gudmundsson G, Snaedal J, Johannesson T. Copper, ceruloplasmin and superoxide dismutase (SOD) in amyotrophic lateral sclerosis. Pharmacol Toxicol 2000; 87: 126-130.
40. Bowling AC, Barkowski EE, McKenna-Yasek D, et al. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem 1995; 64: 2366-2369.
41. O'Reilly SA, Roedica J, Nagy D, et al. Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis. Exp Neurol 1995; 131:203-210.
42. Ihara Y, Mori A, Hayabara T, et al. Superoxide dismutase and free radicals in sporadic amyotrophic lateral sclerosis: relationship to clinical data. J Neurol Sci 1995; 134: 51-56.
43. Cohen O, Kohen R, Lavon E, Abramsky O, Steiner I. Serum Cu/Zn superoxide dismutase activity is reduced in sporadic amyotrophic lateral sclerosis patients. J Neurol Sci 1996; 143:118-120.
44. Reiser S, Smith JC Jr, Mertz W, et al. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am J Clin Nutr 1985; 42: 242-251.
45. Iwasaki Y, Shiojima T, Kinoshita M. Superoxide dismutase activity in amyotrophic lateral sclerosis. J Neurol Sci 1997 152:226-229.
46. Bruce B, Spiller GA, Klevay LM, Gallagher SK. A diet high in whole and unrefined foods favorably alters lipids, antioxidant defenses, and colon function. J Am Coll Nutr 2000; 19: 61-67.
47. Nadif R, Bourgkard E, Dusch M, et al. Relations between occupational exposure to coal mine dusts, erythrocyte catalase and Cu++/Zn++ superoxide dismutase activities, and the severity of coal workers' pneumoconiosis. Occup Environ Med 1998; 55: 533-540.
48. Panemangalore M, Dowla HA, Byers ME. Occupational exposure to agricultural chemicals: effect on the activities of some enzymes in the blood of farm workers. Int Arch Occup Environ Health 1999; 72: 84-88.
49. Jian L, Hu D. Antioxidative stress response in workers exposed to carbon disulfide. Int Arch Occup Environ Health 2000;73:503-506.
50. Ceballos-Picot I, Trivier JM, Nicole A, Sinet PM, Thevenin M. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem 1992; 38: 66-70.
51. WHO. Trace elements in human nutrition and health. Geneva: World Health Organization, 1996.
52. Garcia-Redondo A, Bustos F, Juan Y Seva B, et al. Molecular analysis of the superoxide dismutase 1 gene in Spanish patients with sporadic or familial amyotrophic lateral sclerosis. Muscle Nerve 2002; 26: 274-278.
53. Llanos RM, Mercer JF. The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol 2002; 21: 259-270.
54. Radunovic A, Delves HT, Robberecht W, et al. Copper and zinc levels in familial amyotrophic lateral sclerosis patients with CuZnSOD gene mutations. Ann Neurol 1997; 42: 130-131.
55. Pamphlett R, McQuilty R, Zarkos K. Blood levels of toxic and essential metals in motor neuron disease. Neurotoxicology 2001;22:401-410.